ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Synovial fluid calprotectin quantitative rapid diagnostic biomarker for risk stratification of periprosthetic joint infections.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDiagnosing periprosthetic joint infections (PJI) are challenging and may be hampered by the presence of other causes of local inflammation. Recently, several synovial biomarkers have been introduced into the algorithm for the diagnosis of a PJI. Calprotectin is a protein that is present in the cytoplasm of neutrophils, is released upon neutrophil activation, and exhibits antimicrobial activity. The purpose of this study is to demonstrate calprotectin as a promising biomarker for the diagnosis of PJIs.
methodsThis retrospective single-center study (Dec 2020-Nov 2023) included 52 patients undergoing revision arthroplasty on the grounds of confirmed or suspected infection as per the criteria of the Infectious Diseases Society of America (IDSA) for PIJs. Synovial fluid calprotectin was measured intraoperatively using a quantitative lateral flow assay. Diagnostic accuracy was evaluated against tissue culture using ROC analysis, Cohen's kappa, sensitivity, and specificity.
resultsRevision procedures included hip (44%), knee (25%), and shoulder (8%) arthroplasties. Calprotectin testing indicated high infection risk in 40.4% of patients, while periprosthetic tissue cultures were positive in 53.8%. Agreement between the tests was good (Cohen's kappa = 0.735). Calprotectin testing showed a sensitivity of 75%, specificity of 100%, positive predictive value of 100%, negative predictive value of 78%, and an area under the receiver operating characteristic curve of 0.875.
conclusionThe study highlights the diagnostic value of synovial fluid calprotectin as a diagnostic biomarker with high sensitivity and specificity in the diagnosis of PJI.
Indexed as
Identifiers
40418399What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.